share_log

昭衍新药关于上海证券交易所对公司2023年年度报告的信息披露监管工作函的回复公告

Announcement of Zhaoyan Pharmaceutical's response to the Shanghai Stock Exchange's letter on the information disclosure supervision of the company's 2023 annual report

Sensex a share ·  May 28
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more